{
  "id": 1938381,
  "title": "SA and Zambia’s HIV shot dilemma: Demand versus supply",
  "url": "https://urgent.news/2026/08/19/sa-and-zambias-hiv-shot-dilemma-demand-versus-supply-1938381",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-19T12:33:30.000Z",
  "source": {
    "name": "Mail and Guardian",
    "slug": "mail-and-guardian",
    "url": "https://mg.co.za/news/health/2026-08-19-sa-and-zambia-s-hiv-shot-dilemma-demand-versus-supply/"
  },
  "original_language": "en",
  "account": null,
  "summary": "South Africa and Zambia are grappling with a significant challenge in rolling out lenacapavir, a new six-monthly HIV prevention injection. Despite high demand and promising early results, limited supplies mean clinics often run out of stock, creating a complex balancing act between generating awareness and ensuring equitable access.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Bhekisisa",
        "title": "SA and Zambia’s HIV shot dilemma: Demand versus supply",
        "url": "https://urgent.news/2026/08/19/sa-and-zambias-hiv-shot-dilemma-demand-versus-supply",
        "published": "2026-08-19T03:30:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}